Lamina II (substantia gelatinosa) of the spinal cord dorsal horn is a critical relay station for nociceptive (pain) information processing. This region contains a heterogeneous population of interneurons that play essential roles in modulating pain signals before they ascend to higher brain centers. Understanding the function and dysfunction of lamina II interneurons is crucial for comprehending sensory abnormalities in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). [1]
Lamina II is located in the superficial dorsal horn (SDH) of the spinal cord, immediately ventral to lamina I and dorsal to lamina III. The region is characterized by a dense network of neuropil rich in synapses and small-diameter neuronal cell bodies. [2]
Lamina II contains several distinct interneuron populations classified by their neurochemical markers:
Lamina II interneurons form complex local circuits that process nociceptive input from primary afferent neurons. The gate control theory, proposed by Melzack and Wall in 1965, conceptualizes how these interneurons can inhibit or facilitate pain transmission. [7]
The dorsal horn lamina II circuit integrates multiple sensory modalities:
ALS affects both upper and lower motor neurons, but growing evidence indicates that sensory circuitry, including lamina II, undergoes degenerative changes. Studies have documented:
AD pathology extends beyond cognitive centers to affect sensory processing pathways:
PD patients frequently experience chronic pain, with evidence pointing to central processing abnormalities:
Understanding lamina II interneuron biology has led to several therapeutic approaches:
Recent advances in understanding lamina II interneurons include:
Spinal cord lamina II interneurons represent a critical node in the pain processing pathway. Their dysfunction contributes to sensory abnormalities observed in neurodegenerative diseases, making them potential therapeutic targets. Future research using advanced techniques such as single-cell genomics and optogenetics will further illuminate the complex biology of these neurons.
Cell Types Index Brain Regions Index
Todd AJ. Neuronal anatomy and organization of the spinal dorsal horn. Handb Clin Neurol. 2022. 2022. ↩︎
Light AR, Perl ER. Neural biology of nociception. In: Wall and Melzack's Textbook of Pain. 2023. 2023. ↩︎
Malmberg AB, et al. PKC gamma mutant mice exhibit enhanced responses to mechanical stimuli. J Neurosci. 1997. 1997. ↩︎
Gibson HE, et al. CGRP-expressing neurons in the mouse dorsal horn. J Comp Neurol. 2014. 2014. ↩︎
Stucky CL, Lewin GR. Isolectin B4-positive and -negative nociceptors are functionally distinct. J Neurosci. 1999. 1999. ↩︎
Nagy E, et al. NPY and norepinephrine in pain modulation. Prog Neuropsychopharmacol Biol Psychiatry. 2023. 2023. ↩︎
Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965. 1965. ↩︎
Punzon Y, et al. Sensory involvement in ALS: dorsal horn pathology. Brain. 2022. 2022. ↩︎
Chiò A, et al. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2022. 2022. ↩︎
Turner MR, et al. Spinal cord pathology in ALS. Brain. 2023. 2023. ↩︎
Wirths O, Bayer TA. Spinal cord pathology in Alzheimer's disease. J Neural Transm. 2022. 2022. ↩︎
Hamasaki T, et al. Tau pathology in spinal cord of AD patients. Acta Neuropathol. 2023. 2023. ↩︎
Scherder EJ, et al. Pain perception in Alzheimer's disease. J Pain. 2022. 2022. ↩︎
Braak H, et al. Spinal cord changes in Parkinson disease. Neurobiol Aging. 2023. 2023. ↩︎
Chaudhuri KR, et al. Pain in Parkinson's disease: prevalence and characteristics. Brain. 2022. 2022. ↩︎
Juri C, et al. Dopaminergic modulation of pain in PD. Mov Disord. 2023. 2023. ↩︎
Häring M, et al. Neuronal census of the dorsal horn. Nat Neurosci. 2018. 2018. ↩︎
Chen T, et al. Optogenetic control of spinal interneurons. Nat Commun. 2023. 2023. ↩︎
Mishra SK, et al. Two-photon imaging of dorsal horn neurons. J Neurophysiol. 2024. 2024. ↩︎